Bronchiectasis Therapeutic Market - Top Companies and Manufacturers

Companies Dominating the Bronchiectasis Therapeutic Landscape

GlaxoSmithKline Plc
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Reckitt and Benckiser Group Plc
Zydus Pharmaceuticals, Inc.
Teva Pharmaceutical Industries Ltd.
Merck & Co., Inc.
Insmed Inc.
Reddy’s Laboratories Ltd
Pfizer Inc.
Janssen Pharmaceuticals, Inc.
Boehringer Ingelheim International GmbH

Browse Key Market Insights with Data Illustration:

Bronchiectasis Therapeutic Market Size & Share, Forecast Report 2036

In the News

GlaxoSmithKline Pharmaceuticals released Trelegy Ellipta to patients with chronic obstructive pulmonary disease in April 2022.
The first generic version of twice daily PERFOROMIST, a formoterol fumarate inhalation solution, 20 mcg/2 ml, for the treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema, was officially launched by Teva Pharmaceuticals, a subsidiary of Teva Pharmaceutical Industries Ltd., in June 2021.

Frequently Asked Questions (FAQ)

The growing prevalence of respiratory disease and growing awareness about the disease are some of the major factors anticipated to drive the growth of the bronchiectasis therapeutics market.

The market is anticipated to attain a CAGR of ~6% over the forecast period, i.e., 2024-2036.

The major players in the market are Zydus Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Insmed Inc., Reddyâ€™s Laboratories Ltd, and others.

The online pharmacy segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in North America is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.

Bronchiectasis Therapeutic Market - Top Companies and Manufacturers

Companies Dominating the Bronchiectasis Therapeutic Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What are the major factors driving the growth of the bronchiectasis therapeutics market?

What would be the CAGR of the bronchiectasis therapeutics market over the forecast period?

Who are the major players dominating the bronchiectasis therapeutics market?

Which segment captures the significant market size in the distribution channel in the bronchiectasis therapeutics market?

Which region will provide more business opportunities for the growth of the bronchiectasis therapeutics market in the future?